Update on the detection and treatment of atherogenic low-density lipoproteins
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Update on the detection and treatment of atherogenic low-density lipoproteins
Authors
Keywords
-
Journal
Current Opinion in Endocrinology Diabetes and Obesity
Volume 20, Issue 2, Pages 140-147
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2013-08-31
DOI
10.1097/med.0b013e32835ed9cb
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- DPP-4 Inhibitors and Lipids: Systematic Review and Meta-Analysis
- (2012) Matteo Monami et al. ADVANCES IN THERAPY
- Meta-Analysis of Comparison of Effectiveness of Lowering Apolipoprotein B Versus Low-Density Lipoprotein Cholesterol and Nonhigh-Density Lipoprotein Cholesterol for Cardiovascular Risk Reduction in Randomized Trials
- (2012) Jennifer G. Robinson et al. AMERICAN JOURNAL OF CARDIOLOGY
- Statin Therapy in the Prevention of Recurrent Cardiovascular Events
- (2012) Jose Gutierrez et al. ARCHIVES OF INTERNAL MEDICINE
- Discordance analysis of Apolipoprotein B and non-high density lipoprotein cholesterol as markers of cardiovascular risk in the INTERHEART study
- (2012) Allan D. Sniderman et al. ATHEROSCLEROSIS
- Lipids and Lipoproteins and Risk of Different Vascular Events in the MRC/BHF Heart Protection Study
- (2012) Sarah Parish et al. CIRCULATION
- Determinants of Residual Risk in Secondary Prevention Patients Treated With High- Versus Low-Dose Statin Therapy
- (2012) Samia Mora et al. CIRCULATION
- Low-Density Lipoprotein Cholesterol–Lowering Effects of AMG 145, a Monoclonal Antibody to Proprotein Convertase Subtilisin/Kexin Type 9 Serine Protease in Patients With Heterozygous Familial Hypercholesterolemia
- (2012) Frederick Raal et al. CIRCULATION
- Apolipoprotein B Synthesis Inhibition With Mipomersen in Heterozygous Familial Hypercholesterolemia
- (2012) Evan A. Stein et al. CIRCULATION
- Low-density lipoprotein-lowering strategies
- (2012) Allan D. Sniderman et al. CURRENT OPINION IN CARDIOLOGY
- Association of LDL Cholesterol, Non–HDL Cholesterol, and Apolipoprotein B Levels With Risk of Cardiovascular Events Among Patients Treated With Statins
- (2012) S. Matthijs Boekholdt et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of a Monoclonal Antibody to PCSK9 on Low-Density Lipoprotein Cholesterol Levels in Statin-Intolerant Patients
- (2012) David Sullivan et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Fatty acids in cardiovascular health and disease: A comprehensive update
- (2012) Seth J. Baum et al. Journal of Clinical Lipidology
- Dietary fats and coronary heart disease
- (2012) W. C. Willett JOURNAL OF INTERNAL MEDICINE
- Molecular characterization of proprotein convertase subtilisin/kexin type 9-mediated degradation of the LDLR
- (2012) Yan Wang et al. JOURNAL OF LIPID RESEARCH
- Effects of AMG 145 on Low-Density Lipoprotein Cholesterol Levels
- (2012) Clapton S. Dias et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Niacin and Statin Combination Therapy for Atherosclerosis Regression and Prevention of Cardiovascular Disease Events
- (2012) Erin D. Michos et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- On-Treatment Non–High-Density Lipoprotein Cholesterol, Apolipoprotein B, Triglycerides, and Lipid Ratios in Relation to Residual Vascular Risk After Treatment With Potent Statin Therapy
- (2012) Samia Mora et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Safety and Efficacy of a Monoclonal Antibody to Proprotein Convertase Subtilisin/Kexin Type 9 Serine Protease, SAR236553/REGN727, in Patients With Primary Hypercholesterolemia Receiving Ongoing Stable Atorvastatin Therapy
- (2012) James M. McKenney et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The Controversies of Statin Therapy
- (2012) J. Wouter Jukema et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Effect of a monoclonal antibody to PCSK9, REGN727/SAR236553, to reduce low-density lipoprotein cholesterol in patients with heterozygous familial hypercholesterolaemia on stable statin dose with or without ezetimibe therapy: a phase 2 randomised controlled trial
- (2012) Evan A Stein et al. LANCET
- ApoB-containing lipoproteins regulate angiogenesis by modulating expression of VEGF receptor 1
- (2012) Inbal Avraham-Davidi et al. NATURE MEDICINE
- Effect of a Monoclonal Antibody to PCSK9 on LDL Cholesterol
- (2012) Evan A. Stein et al. NEW ENGLAND JOURNAL OF MEDICINE
- Atorvastatin with or without an Antibody to PCSK9 in Primary Hypercholesterolemia
- (2012) Eli M. Roth et al. NEW ENGLAND JOURNAL OF MEDICINE
- Identification of a Danger-Associated Peptide From Apolipoprotein B100 (ApoBDS-1) That Triggers Innate Proatherogenic Responses
- (2011) Daniel F.J. Ketelhuth et al. CIRCULATION
- A Meta-Analysis of Low-Density Lipoprotein Cholesterol, Non-High-Density Lipoprotein Cholesterol, and Apolipoprotein B as Markers of Cardiovascular Risk
- (2011) Allan D. Sniderman et al.
- Comparison of aerobic exercise, diet or both on lipids and lipoproteins in adults: A meta-analysis of randomized controlled trials
- (2011) George A. Kelley et al. CLINICAL NUTRITION
- Effect of bile acid sequestrants on glucose metabolism, hepatic de novo lipogenesis, and cholesterol and bile acid kinetics in type 2 diabetes: a randomised controlled study
- (2011) C. Beysen et al. DIABETOLOGIA
- Statins for Primary Prevention of Cardiovascular and Cerebrovascular Events in Diabetic Patients without Established Cardiovascular Diseases: A Meta-Analysis
- (2011) Y.-H. Chen et al. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
- Clinical implications of discordance between low-density lipoprotein cholesterol and particle number
- (2011) James D. Otvos et al. Journal of Clinical Lipidology
- The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial
- (2011) Colin Baigent et al. LANCET
- Drug Treatment of Hyperlipidaemia
- (2010) Peter P. Toth DRUGS
- Safety of Anacetrapib in Patients with or at High Risk for Coronary Heart Disease
- (2010) Christopher P. Cannon et al. NEW ENGLAND JOURNAL OF MEDICINE
- n–3 Fatty Acids and Cardiovascular Events after Myocardial Infarction
- (2010) Daan Kromhout et al. NEW ENGLAND JOURNAL OF MEDICINE
- Major Lipids, Apolipoproteins, and Risk of Vascular Disease
- (2009) The Emerging Risk Factors Collaboration* JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Age as a modifiable risk factor for cardiovascular disease
- (2008) Allan D Sniderman et al. LANCET
- Inhibition of microsomal triglyceride transfer protein alone or with ezetimibe in patients with moderate hypercholesterolemia
- (2008) Frederick F Samaha et al. Nature clinical practice. Cardiovascular medicine
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started